ZVRA 主要統計
高い
9.99
オープン
9.53
取引高
1.51M
低い
9.47
前日終値
9.53
売買代金
14.76M
52週高値
15.04
相対取引高
0.961
変動幅 (%)
5.46%
52週安値
7.16
売買回転率
2.57%
時価総額
563.07M
PER（TTM）
4.42
PER（年次）
6.807
PBR
2.74
PSR
4.61
1株当たり利益（EPS）
2.154
配当（TTM）
0
配当利回り
0.00%
発行済株式数
59.11M
通貨単位
USD
ZVRA 価格パフォーマンス
7 日
30 日
90 日
180 日
年初来
1 年
ZVRA マネーフロー分布
ZVRA 日次空売り出来高
ZVRA ショートインタレスト履歴
ZVRA 株式スナップショット
As of 2026-07-27, the Zevra Therapeutics, Inc. (ZVRA) stock price today is 9.71. Based on this price, the company has a market capitalization of $563.07M, with a P/E ratio of 4.42.
On 2026-07-27, ZVRA traded between 9.47 and 9.99. Today’s stock price is 2.53% above the daily low and 2.80% below the daily high, placing ZVRA 中央付近 its most recent trading range.
Trading volume currently stands at 1.51M, compared with an average daily volume of 1.58M. This suggests that trading activity is 通常水準とほぼ同じ than usual.
Over the past year, Zevra Therapeutics, Inc. shares have traded between 7.16 and 15.04. At today’s price, ZVRA is 35.61% above its 52-week low and 35.44% below its 52-week high.
ZVRA 関連ニュース
について ZVRA
企業名
Zevra Therapeutics, Inc.
セクター
Health Technology
業種
Pharmaceuticals: Major
取引所
Nasdaq
従業員数
61
ロットサイズ
100
公式サイト
通貨単位
USD
Zevra Therapeutics Inc is a commercial-stage company with a late-stage pipeline committed to bringing life-changing therapeutics to people living with rare diseases. The Company is focused on expanding patient access, progressing its pipeline toward key milestones, and delivering meaningful outcomes for patients with unmet needs. The commercialization of its product, marketed in the United States for Niemann-Pick disease type C (NPC), a rare, progressive neurodegenerative disease, provides a corporate foundation and demonstrates its ability to advance therapies from development to market.
Related Stocks
